openPR Logo
Press release

Human Vaccines Market Research Report Forecast to 2024

09-18-2017 09:08 AM CET | Health & Medicine

Press release from: Transparency Market Research

Human Vaccines Market

Human Vaccines Market

The global human vaccines market was valued at US$28.3 bn in 2015 and is estimated to reach US$72.5 bn by 2024, registering an 11.2% CAGR during the forecast period.

By age group, pediatric vaccines accounted for a 57.5% share in the global human vaccines market in 2015. Adult vaccines, on the other hand, are expected to expand at a 13.2% CAGR from 2016 to 2024. Based on product, the pneumococcal segment accounted for the majority share in in 2015, with the hepatitis segment exhibiting strong growth during the forecast period.

On basis of vaccine type, the conjugate vaccines segment accounted for the majority share in the global human vaccines market in 2015. On the other hand, the combination vaccines segment is expected to expand at an outstanding CAGR from 2016 to 2024. By distribution channel, the hospital pharmacies segment led the global human vaccines market. However, the drugstores segment is projected to expand at a considerable pace through 2024.

Geographically, North America dominates the global human vaccines market and is estimated to reach a value of US$28.0 bn by 2024. Asia Pacific is the most promising market for human vaccines and is expected to expand at a high CAGR of 12.5% during the forecast period.

An extremely low risk of serious and fatal side effects associated with vaccines is one of the primary factors driving the market for human vaccines around the world. Similar to other drugs, vaccines are associated with a few side effects; however, most of the times, these are rather mild. Soreness, swelling, redness at the site of injection, fever, rash, or itchiness are the most common side effects of vaccines. Several healthcare organizations, including the Centers for Disease Control and Prevention (CDC), the US FDA, the American Medical Association (AMA), and the American Academy of Pediatrics (AAP) recommend the use of vaccines owing to their safety.

Complementing this factor is the growing awareness among patients and the general population regarding the benefits of vaccination. This can be attributed to a rise in awareness programs by government, private, and not-for-profit organizations. “The celebration of the National Immunization Awareness Month in the month of August in the U.S., for instance, is a great way of spreading awareness and getting more people to opt for vaccination,” the author of the report states.

Request to view Sample Report: http://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=16127

Strict regulatory requirements is a major hurdle for most players in the global human vaccines market. In addition to this, high costs pose a significant challenge. “The discovery and development of new vaccines require immense capital. Moreover, the transportation, storage, and handling of vaccines can also be extremely heavy on the pocket,” the TMR analyst reports. Apart from this, the containment of technical expertise in the hands of a few major players also acts as a deterrent on the growth of the human vaccines market.

Request to Download TOC of the Report: http://www.transparencymarketresearch.com/report-toc/16127

The global human vaccines market is dominated by GlaxoSmithKline plc., Sanofi, Pfizer, Inc., and Merck & Co, Inc. These players collectively accounted for over 70% of the market in terms of revenue in 2015. Analysts at Transparency Market Research have identified some of the key strategies adopted by players in the human vaccines market in order to gain a competitive edge over the rest. These include mergers and acquisitions, collaborations and acquisitions for market penetration, the establishment of local production sites, the expansion of product portfolios, and expansion activities in regions with high growth potential.

A focus on research and development is also a successful growth strategy, TMR finds. For instance, Pfizer, Inc. has always focused on R&D in order to improve innovation and productivity. It is presently working on various pipeline products for different therapies and innovating new capabilities that can position it for long-term leadership across the globe.

Global Human Vaccines Market Report is available @ US$ 5795 : http://www.transparencymarketresearch.com/checkout.php?rep_id=16127<ype=S

About Us

Transparency Market Research (TMR) is a market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants, use proprietary data sources and various tools and techniques to gather, and analyze information. Our business offerings represent the latest and the most reliable information indispensable for businesses to sustain a competitive edge.

Contact us:

Transparency Market Research
90 State Street,
Suite 700,
Albany
NY - 12207
United States
Tel: +1-518-618-1030
USA - Canada Toll Free 866-552-3453
Email: sales@transparencymarketresearch.com
Website: http://www.transparencymarketresearch.com/

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Human Vaccines Market Research Report Forecast to 2024 here

News-ID: 721839 • Views: 215

More Releases from Transparency Market Research

Impact of Outbreak of COVID-19 on Medical Education Market : Global Industry Ana …
Transparency Market Research (TMR) has published a new report on the medical education market for the period of 2019–2027. According to the report, the global medical education market was valued at nearly US$ 31 Bn in 2018, and is projected to expand at a CAGR of more than 4% from 2019 to 2027. Rise in the number of medical schools and increase in cost of medical education are the
Healthcare BI Platform Market Companies Analysis, Advancement and Precise Outloo …
In an intensely competitive healthcare business intelligence (BI) platform market, large players are aggressively focused on expanding their geographical outreach, says Transparency Market Research (TMR) in a new market intelligence report. These large players are leveraging the cloud business model to provide healthcare BI solutions that can be accessed irrespective of location. Apart from this, savvy players are entering into partnerships with hospital groups and healthcare bodies to integrate healthcare BI
Substance Abuse Treatment Market News Research Report 2024
A recent report by Transparency Market Research on the substance abuse treatment market in the U.S. states that the competitive landscape is highly fragmented. This is because around 242 companies compete against one another in it. This also makes overall competition stiff. Some of the companies that have beat competition to emerge as leading players in the market are Pfizer Inc., Alkermes Plc, GlaxoSmithKline Plc., and Purdue Pharma LP. Their
Clinical Oncology Next Generation Sequencing Market is Thriving Worldwide By Siz …
Clinical Oncology Next Generation Sequencing: Introduction Next generation sequencing for tumor and germline DNA is required for oncology screening for therapeutic application. Rise in burden of cancer increases the need for early detection of the condition to carry out the generate target therapy. Companies are investing to develop technologically advanced devices/solutions for precision detection. In 2012, Oxford Nanopore had launched the GridION sequencing platform, which can sequence a human genome in 15

All 5 Releases


More Releases for Human

Human Physiology 2019
Human Physiology 2019 Theme: Exploring the Principles of Physiology & Metabolism September 16-17, 2019 | London, United Kingdom Lexis Conferences cordially invites all the members of different nations to attend this annual meet which is scheduled to hold on September 16-17, 2019 at London, United Kingdom based on theme Exploring the Principles of Physiology & Metabolism. A two days scientific meet will gather scientists, students and healthcare industries under one roof to build
Human Microbiome Market
Microbial cells outnumber the human cells in the ratio 10:1 in a health human body. Human microbiome is the study of microbes present in the human body. These are beneficial microbes that carry out functions not performed by any gene in the human DNA and hence, they play a very important role in the human body. For example, these microbes produce certain vitamins that our body cannot make, breakdown our
Human Microbiome Market
Microbial cells outnumber the human cells in the ratio 10:1 in a health human body. Human microbiome is the study of microbes present in the human body. These are beneficial microbes that carry out functions not performed by any gene in the human DNA and hence, they play a very important role in the human body. For example, these microbes produce certain vitamins that our body cannot make, breakdown our
Human Microbiome Market
Microbial cells outnumber the human cells in the ratio 10:1 in a health human body. Human microbiome is the study of microbes present in the human body. These are beneficial microbes that carry out functions not performed by any gene in the human DNA and hence, they play a very important role in the human body. For example, these microbes produce certain vitamins that our body cannot make, breakdown our
metamorphis the Human Story
contact: Rosalyn Lifshin, Executive Director Ocean City Arts Center, rozl@oceancityartscenter.orgCo (609) 399-7628
Human Resources or Human Capital?
Are people really an organisation's most important asset? Not necessarily. Some are liabilities – but some undoubtedly are the most important drivers of value that an organisation has. The question is – who are they? How do we know? How can we maximise the value they have and the value they provide? These questions are what human capital management is about. This book explains the answers and discusses approaches